Search

everythinglearnresearchcommunity

for

Search:↓

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Finasteride blocks progesterone's effect on absence seizures in rats.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Latanoprost can make eyelashes longer, thicker, and darker.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

These medications for BPH have known risks and may have new side effects.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Progesterone can reduce seizures without relying on the GABAA receptor pathway.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.